Signal mining and analysis of adverse events of Brentuximab Vedotin base on FAERS and JADER databases is a research paper published in PLOS One (2025). On theSindex it has a DataRank of 0.307. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0383
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Kunming Health Care Commission's Health Research Project
Grant: 2023-13-01-017
The Scientific Research Fund Project of the Yunnan Provincial Department of Education
Grant: 2024J0371
Yunnan Provincial Association of Pharmacists in Healthcare Facilities Scientific Research Special Fund Project
Grant: 2024YSXH06
Thousand Project Programme of kunming health Science and Technology Talent Cultivation
Grant: 2023-SW (back-up)-84
FWCI
1.90
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals